Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**hyaluronic acid + polycarbophil** is a combination of two polymers, used primarily in vaginal moisturizing gels and topical formulations for the treatment of vulvovaginal atrophy, dryness, and related symptoms. *Hyaluronic acid* is a naturally occurring biopolymer with strong water-binding and viscoelastic properties, facilitating hydration, tissue repair, and scaffolding for cell proliferation. *Polycarbophil* is a synthetic polymer notable for its bioadhesive and mucoadhesive properties, enabling prolonged contact and water retention on mucosal surfaces. The combination provides sustained moisturization, improved vaginal health indices, and optimal safety profiles for vaginal dryness, with both ingredients acting locally through physical hydrating and film-forming mechanisms rather than systemic pharmacological activity[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hyaluronic acid + polycarbophil.